126 related articles for article (PubMed ID: 17671203)
1. Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.
Arwert E; Hingtgen S; Figueiredo JL; Bergquist H; Mahmood U; Weissleder R; Shah K
Cancer Res; 2007 Aug; 67(15):7335-42. PubMed ID: 17671203
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of the dynamics of different variants of EGFR in glioblastomas.
Shah K
Methods Mol Biol; 2011; 680():153-64. PubMed ID: 21153380
[TBL] [Abstract][Full Text] [Related]
3. Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation.
Wang H; Shi B; Zhang Q; Jiang H; Hu S; Kong J; Yao M; Yang S; Li Z
FASEB J; 2012 Jan; 26(1):73-80. PubMed ID: 21917986
[TBL] [Abstract][Full Text] [Related]
4. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of irradiation on human gliomas growth in vitro and in vivo after epidermal growth factor receptor silencing with RNA interference.
Cui G; Zhang T; Wei L; Du P; Zhang F; Chen B; Yin Q; Yan L; Wei J
Neuroreport; 2011 Oct; 22(15):773-7. PubMed ID: 21876467
[TBL] [Abstract][Full Text] [Related]
6. Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.
Ohno M; Natsume A; Ichiro Iwami K; Iwamizu H; Noritake K; Ito D; Toi Y; Ito M; Motomura K; Yoshida J; Yoshikawa K; Wakabayashi T
Cancer Sci; 2010 Dec; 101(12):2518-24. PubMed ID: 20880333
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III.
Fukai J; Nishio K; Itakura T; Koizumi F
Cancer Sci; 2008 Oct; 99(10):2062-9. PubMed ID: 19016767
[TBL] [Abstract][Full Text] [Related]
9. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
[TBL] [Abstract][Full Text] [Related]
10. Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo.
Wang W; Dai LX; Zhang S; Yang Y; Yan N; Fan P; Dai L; Tian HW; Cheng L; Zhang XM; Li C; Zhang JF; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
Neoplasma; 2013; 60(3):274-83. PubMed ID: 23373996
[TBL] [Abstract][Full Text] [Related]
11. MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
Johns TG; McKay MJ; Cvrljevic AN; Gan HK; Taylor C; Xu H; Smyth FE; Scott AM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):572-8. PubMed ID: 20638193
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.
Johns TG; Perera RM; Vernes SC; Vitali AA; Cao DX; Cavenee WK; Scott AM; Furnari FB
Clin Cancer Res; 2007 Mar; 13(6):1911-25. PubMed ID: 17363548
[TBL] [Abstract][Full Text] [Related]
13. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.
Han L; Zhang A; Wang H; Pu P; Jiang X; Kang C; Chang J
Hum Gene Ther; 2010 Apr; 21(4):417-26. PubMed ID: 19899955
[TBL] [Abstract][Full Text] [Related]
14. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.
Martens T; Laabs Y; Günther HS; Kemming D; Zhu Z; Witte L; Hagel C; Westphal M; Lamszus K
Clin Cancer Res; 2008 Sep; 14(17):5447-58. PubMed ID: 18765536
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
[TBL] [Abstract][Full Text] [Related]
20. Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells.
Vollmann A; Vornlocher HP; Stempfl T; Brockhoff G; Apfel R; Bogdahn U
Int J Oncol; 2006 Jun; 28(6):1531-42. PubMed ID: 16685454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
